Business & Finance
Somaxon Pharmaceuticals to Present at Upcoming Investor Conferences
SAN DIEGO--([ BUSINESS WIRE ])--Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company, today announced that Richard W. Pascoe, Somaxona�s president and chief executive officer, is scheduled to present at the following investor conferences:
- Monday, March 7, 2011
Cowen and Company 31st Annual Health Care Conference
The Boston Marriott Copley Place a" Boston, MA
4:00 p.m. ET (1:00 p.m. PT) - Monday, March 14, 2011
Roth 23rd Annual OC Growth Stock Conference
The Ritz Carlton a" Laguna Niguel, CA
12:30 p.m. ET (9:30 a.m. PT) - Wednesday, March 16, 2011
Barclays Capital 2011 Global Healthcare Conference
Loews Miami Beach Hotel a" Miami, FL
3:45 p.m. ET (12:45 p.m. PT)
A live webcast of each presentation will be available in the Investor Relations section of the companya�s Web site under Event Scheduler at [ www.somaxon.com ]. Each webcast will be accessible following conclusion of the live event and archived for approximately 90 days.
To be added to Somaxon Pharmaceuticalsa� email list, please visit [ http://bit.ly/Somaxon-email-list ].
About Somaxon Pharmaceuticals, Inc.
Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and of late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxona�s product Silenor�, now available by prescription in the United States, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.
For more information, please visit the companya�s web site at [ www.somaxon.com ].